Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (30)	3/3/1998 7:28:00 PM
From: John O'Neill	Read Replies (1) \| Respond to of 415

I imagine the unknowns' exist for all type of equity investment. It's particularly difficult to value a small biotech company with no active products in the marketplace. Then again, the reward is great if one enters this type of stock at this price level and all goes well... nothing new ..risk vs reward It's good to know that the biotech value fund would pick up over 10 % of company stock. Webpilot..how do you like the recent TA?..how much slack would you give MCDE to break resistance at $ 9 5/8's ? Has anyone had the chance to call Mat Hogan regarding competition?